Cargando…

Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy

BACKGROUND/AIM: Prostate-specific-membrane-antigen/positron emission tomography (PSMA-PET) detects with high accuracy disease-recurrence, leading to changes in the management of biochemically-recurrent (BCR) prostate cancer (PCa). However, data regarding the oncological outcomes of patients who perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceci, Francesco, Rovera, Guido, Iorio, Giuseppe Carlo, Guarneri, Alessia, Chiofalo, Valeria, Passera, Roberto, Oderda, Marco, Dall’Armellina, Sara, Liberini, Virginia, Grimaldi, Serena, Bellò, Marilena, Gontero, Paolo, Ricardi, Umberto, Deandreis, Désirée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250462/ https://www.ncbi.nlm.nih.gov/pubmed/35217883 http://dx.doi.org/10.1007/s00259-022-05741-9

Ejemplares similares

Predictors of Bone Metastases at (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence
por: Rovera, Guido, et al.
Publicado: (2022)

Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative (68)Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study
por: Rovera, Guido, et al.
Publicado: (2023)

COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses—a Pitfall in [18F]FDG PET/CT
por: Liberini, Virginia, et al.
Publicado: (2021)

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
por: Rizzo, Alessio, et al.
Publicado: (2022)

Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol
por: Marra, Giancarlo, et al.
Publicado: (2022)

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
por: Liberini, Virginia, et al.
Publicado: (2021)

Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?
por: Doolub, Gemina, et al.
Publicado: (2013)

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Impact of segmentation and discretization on radiomic features in (68)Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
por: Liberini, Virginia, et al.
Publicado: (2021)

Re-examining HSPC1 inhibitors
por: Lee, Sheah Lin, et al.
Publicado: (2017)

(225)Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
por: Sathekge, Mike, et al.
Publicado: (2023)

HSPC300 and its role in neuronal connectivity
por: Qurashi, Abrar, et al.
Publicado: (2007)

An unusual case of apical myocarditis: a case report
por: Das, Arka, et al.
Publicado: (2020)

Comparing costs and health care resource utilization between nmHSPC and mHSPC patients: a retrospective claims analysis
por: Ko, Gilbert Chao, et al.
Publicado: (2022)

Oligometastatic Disease Detection with (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
por: Artigas, Carlos, et al.
Publicado: (2021)

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020)

Myocardial Inflammation—Are We There Yet?
por: Greulich, Simon, et al.
Publicado: (2015)

Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments
por: Marra, Giancarlo, et al.
Publicado: (2022)

Flow Dynamics and HSPC Homing in Bone Marrow Microvessels
por: Bixel, M. Gabriele, et al.
Publicado: (2017)

Pelvic salvage (SBRT) radiotherapy based on (68)Ga-PSMA PET/CT: About a case
por: Slaoui, A., et al.
Publicado: (2019)

A VISION Substudy of Reader Agreement on (68)Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for (177)Lu-PSMA-617 Radioligand Therapy
por: Kuo, Phillip H., et al.
Publicado: (2023)

Reproducibility of short axis slice locations in longitudinal cardiovascular magnetic resonance (CMR) studies
por: Kelly, Christopher, et al.
Publicado: (2014)

Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues
por: Nervo, A., et al.
Publicado: (2020)

Randomized prospective phase III trial of (68)Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
por: Calais, Jeremie, et al.
Publicado: (2019)

(68)Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients
por: Liberini, Virginia, et al.
Publicado: (2021)

The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate Cancer
por: Ben Shimol, Jennifer, et al.
Publicado: (2022)

Gaussian modelling for operator-independent and threshold-free volumetric segmentation of phase sensitive inversion recovery late gadolinium enhanced images
por: Piechnik, Stefan K, et al.
Publicado: (2011)

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
por: Calais, Jeremie, et al.
Publicado: (2019)

PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
por: Bianchi, Lorenzo, et al.
Publicado: (2023)

(68)Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy
por: Caroli, Paola, et al.
Publicado: (2020)

Nightmares in Salvage Robot-assisted Radical Prostatectomy After Primary Radiation Therapy for Prostate Cancer: A Step by Step Tutorial
por: Marquis, Alessandro, et al.
Publicado: (2022)

Geographic clonal tracking in macaques provides insights into HSPC migration and differentiation
por: Wu, Chuanfeng, et al.
Publicado: (2018)

(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2017)

A comprehensive quantitative comparison of myocardial motion in mice, rabbits and humans using phase contrast MRI
por: Jung, Bernd A, et al.
Publicado: (2012)

Utilization and impact of cardiovascular magnetic resonance on patient management in heart failure: insights from the SCMR Registry
por: Roifman, Idan, et al.
Publicado: (2022)

Eligibility for (177)Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of (68)Ga-PSMA-11 and (99m)Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
por: Cook, Gary J.R., et al.
Publicado: (2023)

Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
por: Gould, A., et al.
Publicado: (2023)

PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020)

HSPC117 Is Regulated by Epigenetic Modification and Is Involved in the Migration of JEG-3 Cells
por: Ma, Hong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0k0papi7rmimcqaqp747roq8eo